Wipro's AI platform to be used in vaccine safety research

The technology will help identify potential side effects while reducing reliance on animal testing

Wipro has partnered with Transcell Oncologics to use artificial intelligence (AI) in vaccine safety assessments to help predict adverse effects.

The life sciences company has combined its stem cell technology with Wipro HOLMES’s AI capabilities to improve the safety of global vaccine immunisation programmes.

By applying AI to the vaccine development process, the companies hope to predict adverse neurovirulent side effects resulting from vaccinations, reducing the reliance on animal testing in the process.

The deal will also see AI being applied to the repurposing of existing drugs, as well as to stem cell research, in order to measure the safety and potency of new vaccines.

“Enhancing neurovirulence safety assessment through augmented intelligence is a huge step forward in vaccine research and development," said Harmeet Chauhan, Wipro’s global head of engineering and R&D. “This innovative technology allows life science companies and vaccine manufacturers to develop, trial and release safer and more effective vaccines for people around the world.”

Wipro also announced earlier this week it’s investing £16 million over the next four years in a new Innovation Centre that will act as its flagship centre in the UK. The company said it would be integral to providing advanced digital, cyber security and cloud expertise to established and upcoming enterprises, taking the lead on digital transformation in one of Europe’s biggest tech markets.

Related Resource

IT Pro 20/20: Understanding our complicated relationship with AI

The 16th issue of IT Pro 20/20 looks at the very human problems associated with artificial intelligence

IT Pro 20/20: Understanding our complicated relationship with AIDOWNLOAD NOW

UK prime minister Boris Johnson said: “I’m very pleased that Wipro has decided to join the legions of Indian companies investing in the UK, boosting our technology sector and driving economic growth.”

The UK and India agreed on an “Enhanced Trade Partnership” this week which will see 6,500 new jobs created in the UK, of which 2,000 will be created by Indian tech giants Infosys and HCL. Other Indian tech companies are included as well, including MPhasis, which will create 1,000, and Wipro, which will create 500.

Featured Resources

How to choose an AI vendor

Five key things to look for in an AI vendor

Download now

The UK 2020 Databerg report

Cloud adoption trends in the UK and recommendations for cloud migration

Download now

2021 state of email security report: Ransomware on the rise

Securing the enterprise in the COVID world

Download now

The impact of AWS in the UK

How AWS is powering Britain's fastest-growing companies

Download now

Recommended

Toshiba aims to reassemble board after “management chaos”
business management

Toshiba aims to reassemble board after “management chaos”

14 Jun 2021
TSMC plans for new semiconductor plant seen as major win for Japan
Hardware

TSMC plans for new semiconductor plant seen as major win for Japan

11 Jun 2021
Hong Kong considers own centralised digital currency
digital currency

Hong Kong considers own centralised digital currency

10 Jun 2021
Japan and Finland collaborate on 6G development
Network & Internet

Japan and Finland collaborate on 6G development

9 Jun 2021

Most Popular

Ten-year-old iOS 4 recreated as an iPhone app
iOS

Ten-year-old iOS 4 recreated as an iPhone app

10 Jun 2021
Fastly blames software bug for major outage
public cloud

Fastly blames software bug for major outage

9 Jun 2021
GitHub to prohibit code that’s used in active attacks
cyber security

GitHub to prohibit code that’s used in active attacks

7 Jun 2021